BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 117157
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.117157
Table 1 Baseline comparison table in giant hepatic hemangioma group, mean ± SD/n (%)/median (interquartile rage)

Liver subcapsular (n = 55)
Liver parenchymal (n = 17)
t/Z/χ2
P value
Age (years)48.00 ± 9.1247.47 ± 7.54-0.2170.829
Sex0.8720.350
    Female39 (72.72)10 (58.82)
    Male16 (27.27)7 (41.18)
BMI24.26 ± 3.1025.56 ± 3.481.4690.146
Size (cm)10.83 (10.33-13.80)10.50 (10.11-10.90)-1.7110.087
Location of main lesion3.5350.060
    Left lobe18 (30.91)1 (5.88)
    Right lobe37 (69.09)16 (94.12)
Hepatitis B virus3 (5.45)0 (0)
Reasons for operation0.0620.804
    Symptomatic10 (18.2)2 (11.8)
    Enlargement45 (81.8)15 (88.2)
Number of lesions2.1030.349
    119 (34.5)8 (47.1)
    29 (16.4)4 (23.5)
    Multiple27 (49.1)5 (29.4)
Inflammatory
    WBC (109/L)5.34 ± 1.825.06 ± 1.30-0.5810.563
    Neutrophil (%)57.60 (49.43-62.25)55.40 (49.28-63.80)-1.0480.295
    Hb (g/L)127.65 ± 21.51135.29 ± 17.141.3370.186
Liver function
    TB (μmol/L)12.54 ± 4.5612.41 ± 5.72-0.1010.920
    ALT (U/L)15.30 (10.25-28.00)24.5 (11.75-42.75)-1.5330.125
    AST (U/L)15.50 (14.00-19.75)20.50 (16.25-26.50)-1.9200.055
    GGT (U/L)18.00 (11.25-33.75)37.00 (17.75-54.50)-1.3600.174
Coagulation
    PT (seconds)11.62 ± 0.7211.69 ± 1.300.2990.766
    D-D (μg/L)292.00 (145.75-828.25)242.50 (141.00-526.50)-0.9450.345
Renal function
    Cr (μmol/L)65.30 ± 13.4067.41 ± 10.760.5910.556
    BUN (mg/dL)4.86 ± 1.214.79 ± 1.12-0.2070.837


Write to the Help Desk